ライブ
FierceBiotechWith ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity raceFierceBiotechThe new standard for trusted AI in biopharmaEndpoints NewsPost-Hoc Live: How much is everyone in biopharma getting paid?BioWorldAppointments and advancements for June 9, 2026BioWorldFinancings for June 9, 2026BioWorldIn the clinic for June 9, 2026BioWorldOther news to note for June 9, 2026BioWorldRegulatory actions for June 9, 2026Endpoints NewsWuXi AppTec added to Pentagon list of companies linked to Chinese militaryMerck & Co.Merck and Gilead discontinue Phase III KEYNOTE-D46/EVOKE-03 study - The Pharma LetterFierceBiotechBial bails after Parkinson’s fail, axing asset over phase 2 missMerck & Co.Major US Pharma and Biotech Deals of the Past Decade - Global Banking & Finance Review
Endpoints News 2025年12月2日

House passes bill to reauthorize rare pediatric PRV program; Senate next

House passes bill to reauthorize rare pediatric PRV program; Senate next

原文
本文は利用できません。元の情報源をご確認ください。